TrialBMC urology2022

The efficacy of a suppository based on Phenolmicin P3 and Bosexil (Mictalase®) in control of irritative symptoms in patients undergoing thulium laser enucleation of prostate: a single-center, randomized, controlled, open label, phase III study.

Riccardo Bertolo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.